SACCARO JAMES 4
4 · GE HealthCare Technologies Inc. · Filed Jun 5, 2023
Insider Transaction Report
Form 4
SACCARO JAMES
Chief Financial Officer
Transactions
- Award
Common Stock, par value $0.01 per share
2023-06-01+11,900→ 55,743 total - Award
Employee Stock Option (right to buy)
2023-06-01+36,176→ 36,176 totalExercise: $79.83Exp: 2033-06-01→ Common Stock, par value $0.01 per share (36,176 underlying) - Award
Common Stock, par value $0.01 per share
2023-06-01+43,843→ 43,843 total - Award
Common Stock, par value $0.01 per share
2023-06-01+5,950→ 61,693 total - Award
Employee Stock Option (right to buy)
2023-06-01+54,472→ 54,472 totalExercise: $79.83Exp: 2033-06-01→ Common Stock, par value $0.01 per share (54,472 underlying)
Footnotes (6)
- [F1]Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on June 1, 2024 and 50% will vest on June 1, 2025.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.
- [F3]Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026.
- [F4]Award of restricted stock units with respect to GE HealthCare common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.
- [F5]Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026.
- [F6]Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.